{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:23:23Z","timestamp":1774682603778,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00347-022-01793-2","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T10:03:17Z","timestamp":1673517797000},"page":"108-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HLA-B27-positive Uveitis anterior","HLA-B27 positive anterior uveitis"],"prefix":"10.1007","volume":"120","author":[{"given":"Peter","family":"Werkl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"issue":"3","key":"1793_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs\u00a0DA, Nussenblatt\u00a0RB, Rosenbaum\u00a0JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509\u2013516","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1793_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00347-019-01028-x","volume":"117","author":"M Lenglinger","year":"2020","unstructured":"Lenglinger\u00a0M, Pohlmann\u00a0D, Pleyer\u00a0U (2020) Anteriore virale Uveitis. Klinik, diagnostisches Vorgehen und Behandlungsoptionen. Ophthalmologe 117(1):83\u201392","journal-title":"Ophthalmologe"},{"issue":"4","key":"1793_CR3","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3892\/mmr.2017.6248","volume":"15","author":"B Chen","year":"2017","unstructured":"Chen\u00a0B, Li\u00a0J, He\u00a0C, Li\u00a0D, Tong\u00a0W, Zou\u00a0Y et al (2017) Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review). Mol Med Rep 15(4):1943\u20131951","journal-title":"Mol Med Rep"},{"key":"1793_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/art.42315","author":"J Rademacher","year":"2022","unstructured":"Rademacher\u00a0J, Mullner\u00a0H, Diekhoff\u00a0T, Haibel\u00a0H, Igel\u00a0S, Pohlmann\u00a0D et\u00a0al (2022) Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.42315","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1793_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/09273948.2016.1175641","volume":"24","author":"CH Sibley","year":"2016","unstructured":"Sibley\u00a0CH (2016) Autoinflammation and HLA-B27: beyond antigen presentation. Ocul Immunol Inflamm 24(4):460\u2013469","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"1793_CR6","doi-asserted-by":"publisher","first-page":"R158","DOI":"10.1186\/ar4341","volume":"15","author":"RL Roberts","year":"2013","unstructured":"Roberts\u00a0RL, Wallace\u00a0MC, Jones\u00a0GT, van Rij\u00a0AM, Merriman\u00a0TR, Harrison\u00a0A et al (2013) Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity. Arthritis Res Ther 15(5):R158","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1793_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09273948.2016.1185527","volume":"25","author":"K Pathanapitoon","year":"2017","unstructured":"Pathanapitoon\u00a0K, Dodds\u00a0EM, Cunningham\u00a0ET Jr., Rothova\u00a0A (2017) Clinical spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm 25(4):569\u2013576","journal-title":"Ocul Immunol Inflamm"},{"key":"1793_CR8","doi-asserted-by":"publisher","first-page":"608134","DOI":"10.3389\/fimmu.2020.608134","volume":"11","author":"D Wakefield","year":"2020","unstructured":"Wakefield\u00a0D, Clarke\u00a0D, McCluskey\u00a0P (2020) Recent developments in HLA B27 anterior uveitis. Front Immunol 11:608134","journal-title":"Front Immunol"},{"issue":"12","key":"1793_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41584-018-0097-2","volume":"14","author":"JT Rosenbaum","year":"2018","unstructured":"Rosenbaum\u00a0JT, Asquith\u00a0M (2018) The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol 14(12):704\u2013713","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1793_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0002-9394(14)74218-7","volume":"103","author":"A Rothova","year":"1987","unstructured":"Rothova\u00a0A, van Veenedaal\u00a0WG, Linssen\u00a0A, Glasius\u00a0E, Kijlstra\u00a0A, de Jong\u00a0PT (1987) Clinical features of acute anterior uveitis. Am J Ophthalmol 103(2):137\u2013145","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1793_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ajo.2007.11.009","volume":"145","author":"AM Braakenburg","year":"2008","unstructured":"Braakenburg\u00a0AM, de Valk\u00a0HW, de Boer\u00a0J, Rothova\u00a0A (2008) Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol 145(3):472\u2013479","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1793_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","volume":"50","author":"JH Chang","year":"2005","unstructured":"Chang\u00a0JH, McCluskey\u00a0PJ, Wakefield\u00a0D (2005) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 50(4):364\u2013388","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"1793_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/ard.2008.101501","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper\u00a0J, van der Heijde\u00a0D, Landewe\u00a0R, Brandt\u00a0J, Burgos-Vagas\u00a0R, Collantes-Estevez\u00a0E et al (2009) New criteria for inflammatory back pain in patients with chronic back pain: a\u00a0real patient exercise by experts from the assessment of spondyloarthritis international society (ASAS). Ann Rheum Dis 68(6):784\u2013788","journal-title":"Ann Rheum Dis"},{"issue":"10089","key":"1793_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper\u00a0J, Poddubnyy\u00a0D (2017) Axial spondyloarthritis. Lancet 390(10089):73\u201384","journal-title":"Lancet"},{"issue":"3","key":"1793_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.berh.2019.02.010","volume":"32","author":"A Molto","year":"2018","unstructured":"Molto\u00a0A, Sieper\u00a0J (2018) Peripheral spondyloarthritis: concept, diagnosis and treatment. Best Pract Res Clin Rheumatol 32(3):357\u2013368","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"1793_CR16","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.mayocp.2020.02.007","volume":"95","author":"MN Magrey","year":"2020","unstructured":"Magrey\u00a0MN, Danve\u00a0AS, Ermann\u00a0J, Walsh\u00a0JA (2020) Recognizing axial spondyloarthritis: a guide for primary care. Mayo Clin Proc 95(11):2499\u20132508","journal-title":"Mayo Clin Proc"},{"issue":"10080","key":"1793_CR17","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres\u00a0J, Mehandru\u00a0S, Colombel\u00a0JF, Peyrin-Biroulet\u00a0L (2017) Crohn\u2019s disease. Lancet 389(10080):1741\u20131755","journal-title":"Lancet"},{"issue":"10080","key":"1793_CR18","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro\u00a0R, Mehandru\u00a0S, Allen\u00a0PB, Peyrin-Biroulet\u00a0L, Colombel\u00a0JF (2017) Ulcerative colitis. Lancet 389(10080):1756\u20131770","journal-title":"Lancet"},{"issue":"4","key":"1793_CR19","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler\u00a0G, Singh\u00a0A, Kavanaugh\u00a0A, Rubin\u00a0DT (2021) Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology 161(4):1118\u20131132","journal-title":"Gastroenterology"},{"issue":"32","key":"1793_CR20","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.3748\/wjg.v23.i32.5836","volume":"23","author":"LL Troncoso","year":"2017","unstructured":"Troncoso\u00a0LL, Biancardi\u00a0AL, de Moraes\u00a0HV Jr., Zaltman\u00a0C (2017) Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol 23(32):5836\u20135848","journal-title":"World J Gastroenterol"},{"key":"1793_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/978-3-662-60399-4_24","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"J Rademacher","year":"2021","unstructured":"Rademacher\u00a0J, Pleyer\u00a0U, Winterhalter\u00a0S (2021) Spondylarthritis. In: Pleyer\u00a0U (Hrsg) Entz\u00fcndliche Augenerkrankungen. Springer, Berlin, Heidelberg, S\u00a0503\u2013517"},{"issue":"1","key":"1793_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit\u00a0M, van der Heijde\u00a0D, Landewe\u00a0R, Akkoc\u00a0N, Brandt\u00a0J, Chou\u00a0CT et\u00a0al (2011) The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25\u201331","journal-title":"Ann Rheum Dis"},{"key":"1793_CR23","unstructured":"Deutsche Ophthalmologische Gesellschaft e.\u202fV. (2010) Leitlinie Nr.\u00a014a Uveitis anterior. https:\/\/www.dog.org\/wp-content\/uploads\/2009\/09\/LL-Uveitis-anterior-2011-08-03-Endversion.pdf. Zugegriffen: 7. Okt. 2022"},{"issue":"5","key":"1793_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/1120672119856943","volume":"30","author":"A Bernard","year":"2020","unstructured":"Bernard\u00a0A, Seve\u00a0P, Abukhashabh\u00a0A, Roure-Sobas\u00a0C, Boibieux\u00a0A, Denis\u00a0P et al (2020) Lyme-associated uveitis: clinical spectrum and review of literature. Eur J Ophthalmol 30(5):874\u2013885","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"1793_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","volume":"16","author":"P Seve","year":"2017","unstructured":"Seve\u00a0P, Cacoub\u00a0P, Bodaghi\u00a0B, Trad\u00a0S, Sellam\u00a0J, Bellocq\u00a0D et al (2017) Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev 16(12):1254\u20131264","journal-title":"Autoimmun Rev"},{"key":"1793_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/978-3-662-60399-4_22","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"U Pleyer","year":"2021","unstructured":"Pleyer\u00a0U, Quentin\u00a0CD (2021) Virale anteriore Uveitis. In: Pleyer\u00a0U (Hrsg) Entz\u00fcndliche Augenerkrankungen. Springer, Berlin, Heidelberg, S\u00a0475\u2013487"},{"issue":"11","key":"1793_CR27","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/annrheumdis-2014-205358","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon\u00a0M, O\u2019Rourke\u00a0M, Ramasamy\u00a0P, Murphy\u00a0CC, FitzGerald\u00a0O (2015) A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis 74(11):1990\u20131995","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1793_CR28","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1136\/annrheumdis-2014-207151","volume":"74","author":"D Poddubnyy","year":"2015","unstructured":"Poddubnyy\u00a0D, van Tubergen\u00a0A, Landew\u00e9\u00a0R, Sieper\u00a0J, van der Heijde\u00a0D (2015) Development of an ASAS-endorsed recommendation for the early referral of patients with a\u00a0suspicion of axial spondyloarthritis. Ann Rheum Dis 74(8):1483\u20131487","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1793_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00393-011-0892-5","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy\u00a0D, Rudwaleit\u00a0M, Sieper\u00a0J (2012) Fr\u00fche Spondyloarthritiden, Diagnostisches Vorgehen und Screening. Z\u00a0Rheumatol 71(1):19\u201326","journal-title":"Z Rheumatol"},{"issue":"5","key":"1793_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1055\/s-0043-105139","volume":"234","author":"A Heiligenhaus","year":"2017","unstructured":"Heiligenhaus\u00a0A, Kasper\u00a0M, Grajewski\u00a0R (2017) HLA-B27 positive acute anterior uveitis. Klin Monbl Augenheilkd 234(5):652\u2013656","journal-title":"Klin Monbl Augenheilkd"},{"key":"1793_CR31","doi-asserted-by":"publisher","first-page":"1759720X2095173","DOI":"10.1177\/1759720X20951733","volume":"12","author":"J Rademacher","year":"2020","unstructured":"Rademacher\u00a0J, Poddubnyy\u00a0D, Pleyer\u00a0U (2020) Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720X20951733","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"10","key":"1793_CR32","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00417-018-4082-x","volume":"256","author":"MM Zu Hoerste","year":"2018","unstructured":"Zu Hoerste\u00a0MM, Walscheid\u00a0K, Tappeiner\u00a0C, Zurek-Imhoff\u00a0B, Heinz\u00a0C, Heiligenhaus\u00a0A (2018) The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a\u00a0retrospective cohort study. Graefes Arch Clin Exp Ophthalmol 256(10):1985\u20131992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1793_CR33","doi-asserted-by":"publisher","first-page":"e0230560","DOI":"10.1371\/journal.pone.0230560","volume":"15","author":"N Bouzid","year":"2020","unstructured":"Bouzid\u00a0N, Jamilloux\u00a0Y, Chapurlat\u00a0R, Pradat\u00a0P, De Parisot\u00a0A, Kodjikian\u00a0L et al (2020) Impact of systemic treatments on the course of HLA-B27-associated uveitis: a retrospective study of 101\u00a0patients. PLoS ONE 15(3):e230560","journal-title":"PLoS ONE"},{"issue":"4","key":"1793_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/09273940802204519","volume":"16","author":"PA Pacheco","year":"2008","unstructured":"Pacheco\u00a0PA, Taylor\u00a0SR, Cuchacovich\u00a0MT, Diaz\u00a0GV (2008) Azathioprine in the management of autoimmune uveitis. Ocul Immunol Inflamm 16(4):161\u2013165","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"1793_CR35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe\u00a0GJ, Dick\u00a0AD, Brezin\u00a0AP, Nguyen\u00a0QD, Thorne\u00a0JE, Kestelyn\u00a0P et\u00a0al (2016) Adalimumab in patients with active noninfectious uveitis. N\u00a0Engl J Med 375(10):932\u2013943","journal-title":"N Engl J Med"},{"issue":"10050","key":"1793_CR36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen\u00a0QD, Merrill\u00a0PT, Jaffe\u00a0GJ, Dick\u00a0AD, Kurup\u00a0SK, Sheppard\u00a0J et al (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a\u00a0multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388(10050):1183\u20131192","journal-title":"Lancet"},{"issue":"17","key":"1793_CR37","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan\u00a0AV, Dick\u00a0AD, Jones\u00a0AP, McKay\u00a0A, Williamson\u00a0PR, Compeyrot-Lacassagne\u00a0S et al (2017) Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N\u00a0Engl J Med 376(17):1637\u20131646","journal-title":"N Engl J Med"},{"issue":"5","key":"1793_CR38","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M, Rodevand\u00a0E, Holck\u00a0P, Vanhoof\u00a0J, Kron\u00a0M, Kary\u00a0S et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a\u00a0prospective open-label study. Ann Rheum Dis 68(5):696\u2013701","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1793_CR39","doi-asserted-by":"publisher","first-page":"e001161","DOI":"10.1136\/rmdopen-2019-001161","volume":"6","author":"I van der Horst-Bruinsma","year":"2020","unstructured":"van der Horst-Bruinsma\u00a0I, van Bentum\u00a0R, Verbraak\u00a0FD, Rath\u00a0T, Rosenbaum\u00a0JT, Misterska-Skora\u00a0M et al (2020) The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C\u2011View. RMD Open 6(1):e1161. https:\/\/doi.org\/10.1136\/rmdopen-2019-001161","journal-title":"RMD Open"},{"issue":"2","key":"1793_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3899\/jrheum.180312","volume":"46","author":"RE van Bentum","year":"2019","unstructured":"van Bentum\u00a0RE, Heslinga\u00a0SC, Nurmohamed\u00a0MT, Gerards\u00a0AH, Griep\u00a0EN, Koehorst\u00a0C et al (2019) Reduced occurrence rate of acute anterior uveitis in ankylosing spondylitis treated with golimumab\u2014the go-easy study. J\u00a0Rheumatol 46(2):153\u2013159","journal-title":"J Rheumatol"},{"issue":"9","key":"1793_CR41","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/annrheumdis-2016-210931","volume":"76","author":"E Lie","year":"2017","unstructured":"Lie\u00a0E, Lindstrom\u00a0U, Zverkova-Sandstrom\u00a0T, Olsen\u00a0IC, Forsblad-d\u2019Elia\u00a0H, Askling\u00a0J et al (2017) Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register. Ann Rheum Dis 76(9):1515\u20131521","journal-title":"Ann Rheum Dis"},{"key":"1793_CR42","unstructured":"DGRh (2019) Therapie mit Adalimumab. https:\/\/dgrh.de\/dam\/jcr:f0c50d32-101a-4905-99d2-87c816e2becf\/Adalimumab%20ARZT%2011_2019.pdf. Zugegriffen: 19. Aug. 2022"},{"issue":"5","key":"1793_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1055\/a-1741-8104","volume":"239","author":"Y El-Shabrawi","year":"2022","unstructured":"El-Shabrawi\u00a0Y, Rath\u00a0T, Heiligenhaus\u00a0A (2022) Janus Kinase inhibitors: next-generation treatment for uveitis. Klin Monbl Augenheilkd 239(5):695\u2013701","journal-title":"Klin Monbl Augenheilkd"},{"issue":"5","key":"1793_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/acr2.11139","volume":"2","author":"AA Deodhar","year":"2020","unstructured":"Deodhar\u00a0AA, Miceli-Richard\u00a0C, Baraliakos\u00a0X, Marzo-Ortega\u00a0H, Gladman\u00a0DD, Blanco\u00a0R et al (2020) Incidence of uveitis in secukinumab-treated patients with ankylosing spondylitis: pooled data analysis from three phase 3 studies. ACR Open Rheumatol 2(5):294\u2013299","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"1793_CR45","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ophtha.2014.12.033","volume":"122","author":"E Letko","year":"2015","unstructured":"Letko\u00a0E, Yeh\u00a0S, Foster\u00a0CS, Pleyer\u00a0U, Brigell\u00a0M, Grosskreutz\u00a0CL (2015) Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy. Ophthalmology 122(5):939\u2013948","journal-title":"Ophthalmology"},{"issue":"4","key":"1793_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","volume":"120","author":"AD Dick","year":"2013","unstructured":"Dick\u00a0AD, Tugal-Tutkun\u00a0I, Foster\u00a0S, Zierhut\u00a0M, Melissa Liew\u00a0SH, Bezlyak\u00a0V et al (2013) Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology 120(4):777\u2013787","journal-title":"Ophthalmology"},{"issue":"4","key":"1793_CR47","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3346\/jkms.2009.24.4.722","volume":"24","author":"SC Park","year":"2009","unstructured":"Park\u00a0SC, Ham\u00a0DI (2009) Clinical features and prognosis of HLA-B27 positive and negative anterior uveitis in a\u00a0Korean population. J\u00a0Korean Med Sci 24(4):722\u2013728","journal-title":"J Korean Med Sci"},{"issue":"4","key":"1793_CR48","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ajo.2010.04.031","volume":"150","author":"AR Loh","year":"2010","unstructured":"Loh\u00a0AR, Acharya\u00a0NR (2010) Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol 150(4):534\u201342.e2","journal-title":"Am J Ophthalmol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-022-01793-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T10:04:21Z","timestamp":1702375461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-022-01793-2"}},"subtitle":["Klinik, Diagnostik, interdisziplin\u00e4res Management und Therapie","Clinical aspects, diagnostics, interdisciplinary management and treatment"],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1793"],"URL":"https:\/\/doi.org\/10.1007\/s00347-022-01793-2","relation":{"has-translation":[{"id-type":"doi","id":"10.1007\/s00347-023-01960-z","asserted-by":"subject"},{"id-type":"doi","id":"10.1007\/s00347-023-01960-z","asserted-by":"object"}]},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"8 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>J.\u00a0Rademacher:<\/b> A.\u00a0Finanzielle Interessen: Kostenerstattung Kongressteilnahme: Novartis, UCB, AbbVie. \u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Fach\u00e4rztin f\u00fcr Innere Medizin, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Medizinische Klinik f\u00fcr Gastroenterologie, Infektiologie und Rheumatologie; Clinician Scientist, BIH Berlin Institute of Health | Mitgliedschaften: DGRh, DGfI, DGIM, ASAS. <b>P.\u00a0Werkl:<\/b> A.\u00a0Finanzielle Interessen: P.\u00a0Werkl gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt in Sonderfachausbildung an der Universit\u00e4tsaugenklinik Graz\u00a0\u2013 LKH-Universit\u00e4tsklinikum Graz. <b>U.\u00a0Pleyer:<\/b> A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung: Deutsche Forschungsgemeinschaft, BMBF, European Union; Referentenhonorar\/Reisekostenerstattung als passiver Teilnehmer: AbbVie, Alcon, Allergan, Alimera, Bausch und Lomb, Bayer, Novartis, Santen, Thea; Ich, mein Ehe\u2011\/Partner od. Kind(er) halten Patent\/Gesch\u00e4ftsanteile\/Aktien o.\u202f\u00c4. an einer im Bereich der Medizin aktiven Firma: Bayer, Biontech (Aktien)\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Klinik f\u00fcr Augenheilkunde, Charit\u00e9 Universit\u00e4tsmedizin Berlin | Mitgliedschaft\/Funktion in Interessenverb\u00e4nden: Sprecher der Sektion: Uveitis\/DOG seit 2014 | Schwerpunkt wissenschaftlicher klinischer T\u00e4tigkeiten: Leiter der Sprechstunde \u201eTerti\u00e4rzentrum f\u00fcr entz\u00fcndliche Augenerkrankungen\u201c 1994 bis heute | Sekret\u00e4r: Berlin-Brandenburgische Augen\u00e4rzte | Vorstandsmitglied: Deutsche UVEITIS Arbeitsgemeinschaft DUAG e.\u202fV. U.\u00a0Pleyer ist Mitglied des Herausgeberboards von <i>Die Ophthalmologie<\/i>. Er war nicht an der Begutachtung dieses Manuskripts oder an Entscheidungen in Bezug auf dieses Manuskript beteiligt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}